Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142451 |
| CAS No | NA |
| Mol.F. | C23H26N8O4 |
| Mol.Wt. | 478.51 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142452 |
| CAS No | NA |
| Mol.F. | C24H23ClN8O5 |
| Mol.Wt. | 538.95 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142453 |
| CAS No | NA |
| Mol.F. | C36H39Cl2N9O8 |
| Mol.Wt. | 796.66 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142454 |
| CAS No | NA |
| Mol.F. | C14H13ClN4O4S |
| Mol.Wt. | 368.79 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142455 |
| CAS No | NA |
| Mol.F. | C15H15ClN4O5 |
| Mol.Wt. | 366.76 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142456 |
| CAS No | NA |
| Mol.F. | C21H27ClN6O4 |
| Mol.Wt. | 462.94 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142457 |
| CAS No | NA |
| Mol.F. | C8H20N2O8P2 |
| Mol.Wt. | 334.2 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142458 |
| CAS No | NA |
| Mol.F. | C4H12N2O8P2 |
| Mol.Wt. | 278.1 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142459 |
| CAS No | 6949-28-6 |
| Mol.F. | C12H26N2O |
| Mol.Wt. | 214.35 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142460 |
| CAS No | NA |
| Mol.F. | C23H29N9O2 |
| Mol.Wt. | 463.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142461 |
| CAS No | NA |
| Mol.F. | C24H29N9O3 |
| Mol.Wt. | 491.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142462 |
| CAS No | NA |
| Mol.F. | C21H23N9O4 |
| Mol.Wt. | 465.5 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142463 |
| CAS No | NA |
| Mol.F. | C21H24N8O3 |
| Mol.Wt. | 436.5 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142464 |
| CAS No | NA |
| Mol.F. | C21H24N8O3 |
| Mol.Wt. | 436.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142465 |
| CAS No | NA |
| Mol.F. | C17H15N5O8S |
| Mol.Wt. | 449.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142466 |
| CAS No | NA |
| Mol.F. | C17H16N4O7S |
| Mol.Wt. | 420.4 g/mol |
| INV STATUS | UNDER SYNTHESIS |